Advanced glycation end-products are responsible for the impairment of corpus cavernosal smooth muscle relaxation seen in diabetes

被引:72
|
作者
Cartledge, JJ
Eardley, I
Morrison, JFB
机构
[1] St Jamess Univ Hosp, Pyrah Dept Urol, Leeds LS9 7TF, W Yorkshire, England
[2] United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Physiol, Al Ain, U Arab Emirates
关键词
erectile dysfunction; diabetes mellitus; advanced glycation end-products (AGEs); aminoguanidine;
D O I
10.1046/j.1464-410x.2001.00067.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective To determine if advanced glycation products (AGEs) are responsible for the lower neuronal and endothelial-derived nitric oxide (NO)mediated relaxation of corpus cavernosum in tissue in diabetic rats than in control rats. Materials and methods Diabetes was induced in male Wistar rats by an intraperitoneal injection with streptozotocin (60 mg/kg). One group of diabetic rats was given free access to water and standard diet. A second group was given standard diet and aminoguanidine with their water (50 mg/100 mL) from the initiation of diabetes. Two groups of rats that were not diabetic acted as age-matched controls. After 8 weeks animals were killed by cervical dislocation, corpus cavernosal tissue strips harvested and in an organ bath to measure isometric After 90 min of equilibration at optimal resting tension and contraction with 1 mu mol/L noradrenaline, the response to either acetylcholine or electrical field stimulation (EFS) after adding guanethidine (5 mu mol/L) and atropine (1 mu mol/L) was determined for each group. Results There was no difference between the baseline characteristics of all the experimental groups. After 8 weeks the mean body mass and glycosylated haemoglobin (HbA(1c)) were significantly greater in the diabetic than in control animals. Aminoguanidine had no effect on the recorded body mass or HbA(1c). The in vitro relaxation response to the application of acetylcholine or EFS of tissue strips from age-matched control animals fed a standard diet and those supplemented with aminoguanidine were the same. The administration of aminoguanidine to diabetic animals for 8 weeks reversed the expected impaired relaxation response to acetylcholine; the response to EFS was similar. Conclusion AGEs are more prevalent in erectile tissue from diabetic than in control animals. Aminoguanidine reversed the impairment in neuronal and endothelial NO-mediated penile smooth muscle relaxation seen in diabetes. As aminoguanidine prevents AGE formation, erectile dysfunction in diabetes is probably caused partly by the generation of AGEs.
引用
收藏
页码:402 / 407
页数:6
相关论文
共 50 条
  • [21] Glycation reaction and the receptor for advanced glycation end-products (RAGE): foe or friend for life?
    Yamamoto, Yasuhiko
    ANNALS OF NUTRITION AND METABOLISM, 2023, 79 : 70 - 71
  • [22] The effects of advanced glycation end-products on skin and potential anti-glycation strategies
    Wang, Lingyu
    Jiang, Yanfei
    Zhao, Chunyue
    EXPERIMENTAL DERMATOLOGY, 2024, 33 (04)
  • [23] Immunological detection of fructose-derived advanced glycation end-products
    Takeuchi, Masayoshi
    Iwaki, Mina
    Takino, Jun-ichi
    Shirai, Hikari
    Kawakami, Mihoko
    Bucala, Richard
    Yamagishi, Sho-ichi
    LABORATORY INVESTIGATION, 2010, 90 (07) : 1117 - 1127
  • [24] Decreased formation of advanced glycation end-products in peritoneal fluid by carnosine and related peptides
    Alhamdani, Mohamed-Saiel Saeed
    Al-Azzawie, Hasan Fayadh
    Abbas, Fawzi K. H.
    PERITONEAL DIALYSIS INTERNATIONAL, 2007, 27 (01): : 86 - 89
  • [25] Involvement of Advanced Glycation End-products (AGEs) in Alzheimer's Disease
    Takeuchi, Masayoshi
    Kikuchi, Seiji
    Sasaki, Nobuyuki
    Suzuki, Takako
    Watai, Takayuki
    Iwaki, Mina
    Bucala, Richard
    Yamagishi, Sho-ichi
    CURRENT ALZHEIMER RESEARCH, 2004, 1 (01) : 39 - 46
  • [26] Inhibitory effect of fermentation byproducts on formation of advanced glycation end-products
    Ye, Xiu-Juan
    Ng, T. B.
    Nagai, Ryoji
    FOOD CHEMISTRY, 2010, 121 (04) : 1039 - 1045
  • [27] Unexpected Crosslinking and Diglycation as Advanced Glycation End-Products from Glyoxal
    Lopez-Clavijo, Andrea F.
    Duque-Daza, Carlos A.
    Soulby, Andrew
    Canelon, Isolda Romero
    Barrow, Mark
    O'Connor, Peter B.
    JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY, 2014, 25 (12) : 2125 - 2133
  • [28] The effect of advanced glycation end-products and aminoguanidine on TNFα production by rat peritoneal macrophages
    Rashid, G
    Luzon, AA
    Korzets, Z
    Klein, O
    Zeltzer, E
    Bernheim, J
    PERITONEAL DIALYSIS INTERNATIONAL, 2001, 21 (02): : 122 - 129
  • [29] Neuropathy induced by exogenously administered advanced glycation end-products in rats
    Nishizawa, Yusuke
    Wada, Ryu-ichi
    Baba, Masayuki
    Takeuchi, Masayoshi
    Hanyu-Itabashi, Chieko
    Yagihashi, Soroku
    JOURNAL OF DIABETES INVESTIGATION, 2010, 1 (1-2): : 40 - 49
  • [30] Gingival advanced glycation end-products in diabetes mellitus-associated chronic periodontitis: an immunohistochemical study
    Zizzi, A.
    Tirabassi, G.
    Aspriello, S. D.
    Piemontese, M.
    Rubini, C.
    Lucarini, G.
    JOURNAL OF PERIODONTAL RESEARCH, 2013, 48 (03) : 293 - 301